Literature DB >> 25305048

Quantitative assessment of synovitis in Legg-Calvé-Perthes disease using gadolinium-enhanced MRI.

David C Neal1, Jack C O'Brien, Jamie Burgess, Chanhee Jo, Harry K W Kim.   

Abstract

A quantitative method to assess hip synovitis in Legg-Calvé-Perthes disease (LCPD) is not currently available. To develop this method, the areas of synovial enhancement on gadolinium-enhanced MRI (Gd-MRI) were measured by two independent observers. The volume of synovial enhancement was significantly increased in the initial and the fragmentation stages of LCPD (Waldenström stages I and II), with a persistence of synovitis into the reossification stage (stage III). The Gd-MRI method had high interobserver and intraobserver agreements and may serve as a useful method to monitor the effect of various treatments on hip synovitis in LCPD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25305048     DOI: 10.1097/BPB.0000000000000107

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  4 in total

Review 1.  Legg-Calvé-Perthes disease: classifications and prognostic factors.

Authors:  Virginie Rampal; Jean-Luc Clément; Federico Solla
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

2.  Volume of hip synovitis detected on contrast-enhanced magnetic resonance imaging is associated with disease severity after collapse in osteonecrosis of the femoral head.

Authors:  Hiroyuki Hatanaka; Goro Motomura; Satoshi Ikemura; Yusuke Kubo; Takeshi Utsunomiya; Shoji Baba; Yasuharu Nakashima
Journal:  Skeletal Radiol       Date:  2019-01-29       Impact factor: 2.199

3.  Dynamic deformation of the femoral head occurs on weightbearing in Legg-Calves-Perthes disease: a translational pilot study.

Authors:  Alexander Aarvold; Ryan Lohre; Harpreet Chhina; Kishore Mulpuri; Anthony Cooper
Journal:  Bone Jt Open       Date:  2020-11-02

4.  A comparison of subtraction MRI with the standard contrast-enhanced imaging in Perthes' disease.

Authors:  K Jamil; T Walker; E Onikul; C F Munns; D G Little
Journal:  J Child Orthop       Date:  2019-02-01       Impact factor: 1.548

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.